Viewing Study NCT05032495


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2025-12-31 @ 12:06 AM
Study NCT ID: NCT05032495
Status: COMPLETED
Last Update Posted: 2024-04-09
First Post: 2021-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias
Sponsor: Ottawa Heart Institute Research Corporation
Organization:

Study Overview

Official Title: Patient Directed Strategies for Cardiac Arrhythmia
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.
Detailed Description: There will be four study groups:

1. Heart patients who experienced a cardiac arrhythmia while in hospital,
2. Heart patients who did not experience a cardiac arrhythmia while in hospital,
3. Heart patients with an upcoming procedure that have not had a cardiac arrhythmia,
4. Members of the general public.

There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: